# C4 Therapeutics, Inc.: Form 8-K, filed Nov 20, 2024

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2024-11-20
- Accepted by EDGAR: Nov 20, 2024, 12:11 ET
- Period: 2024-11-20
- Accession: 0001628280-24-048593
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000162828024048593/cccc-20241120.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000162828024048593/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000162828024048593/cccc-20241120.htm

Filed Nov 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-048593. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.